Wave Life Sciences to Present at the Third Annual Stifel CNS Day
March 19 2021 - 8:00AM
Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic
medicines company committed to delivering life-changing treatments
for people battling devastating diseases, announced today that Paul
Bolno, MD, MBA, President and Chief Executive Officer and Michael
Panzara, MD, MPH, Chief Medical Officer and Head of Therapeutics
Discovery and Development are scheduled to participate virtually in
an analyst-led fireside chat at the Third Annual Stifel CNS
Day on Wednesday, April 1, 2021 at 11:30 a.m. ET.
A live webcast of the presentation will be available on the
investor relations page of the Wave Life
Sciences corporate website
at http://ir.wavelifesciences.com. A replay of the
presentation will be archived and available at that site for 90
days following the event.
About Wave Life Sciences Wave Life Sciences
(Nasdaq: WVE) is a clinical-stage genetic medicines company
committed to delivering life-changing treatments for people
battling devastating diseases. Wave aspires to develop
best-in-class medicines across multiple therapeutic modalities
using PRISM, the company’s proprietary discovery and drug
development platform that enables the precise design, optimization
and production of stereopure oligonucleotides. Driven by a resolute
sense of urgency, the Wave team is targeting a broad range of
genetically defined diseases so that patients and families may
realize a brighter future. To find out more, please visit
www.wavelifesciences.com and follow Wave on Twitter
@WaveLifeSci.
Investor Contact:Kate
Rausch617-949-4827krausch@wavelifesci.com
Media Contact:Alicia
Suter617-949-4817asuter@wavelifesci.com
Wave Life Sciences (NASDAQ:WVE)
Historical Stock Chart
From Mar 2024 to Apr 2024
Wave Life Sciences (NASDAQ:WVE)
Historical Stock Chart
From Apr 2023 to Apr 2024